SY Pharmtech to run technology transfer business.

Published: 2006-02-06 06:56:00

Updated: 2006-02-06 06:56:00

While the government mulls a third party (toll) manufacturing permission for pharmaceutical products, SY pharmtech (president: Choi Soo-young) announced on Feb. 2 that the company is trying to run a technology transfer business with new drugs to the domestic manufacturers and wholesalers under th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK